Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / mcta-second-draft.docx
mcta-second-draft.docx
Parties
Harkness LLP
Callahan LLP
Hargrove LLP
Penterra Pharmaceuticals Corp
Dates
May 19, 2023
April 28, 2023
May 5, 2023
January 15, 2023
August 14, 2023
Amounts
$1.4
$52,000
$80,000,000
$62,400,000
$75,000
$2,850,000
$40,000
$5,320,000
$1,500,000
$4,200,000
Obligations
("Meridian CRO"), a contract research organization with offices at 9200 Corporate Boulevard, Raleigh, North Carolina 27615, to provide monitoring, data management, safety reporting, and biostatistics services for the Study pursuant to a Master Services Agreement between Sponsor and Meridian CRO dated January 15, 2023 (the "CRO Agreement"); WHEREAS, the Parties intend this Agreement to serve as the master agreement governing the overall relationship between Sponsor and Site Network with respect to the Study, with each participating Site Network member institution executing an Individual Site Agreement substantially in the form attached hereto as Exhibit C, which shall incorporate the terms of this MCTA by reference and set forth the site-specific obligations, budgets, and personnel for each participating institution; and NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: ARTICLE 1 — DEFINITIONS As used in this Agreement, the following capitalized terms shall have the meanings set forth below
Capitalized terms used but not otherwise defined in this Article 1 shall have the meanings ascribed to them elsewhere in this Agreement
located at 6000 Clearwater Drive, San Diego, California 92121, which shall be used by all Sites for the electronic capture, transmission, and management of Study Data in connection with the conduct of the Study
Professor of Oncology at Graystone University Medical Center, 1200 University Avenue, Philadelphia, Pennsylvania 19104, who shall serve as the overall principal investigator for the Study, or such other individual as may be designated in accordance with Section 5
IRB00012847) and the Veridian Central IRB, each of which shall be organized and operated in accordance with 21 C
Site Network shall serve as the central administrative and coordinating entity for its member institutions' participation in the Study